Based on the key measurements obtained from Opthea's financial statements, Opthea may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, Opthea's Common Stock Total Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 228 M in 2025, whereas Net Debt is likely to drop (29.1 M) in 2025. Key indicators impacting Opthea's financial strength include:
The essential information of the day-to-day investment outlook for Opthea includes many different criteria found on its balance sheet. An individual investor should monitor Opthea's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Opthea.
Please note, the imprecision that can be found in Opthea's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Opthea. Check Opthea's Beneish M Score to see the likelihood of Opthea's management manipulating its earnings.
Opthea Stock Summary
Opthea competes with Molecular Partners, MediciNova, Anebulo Pharmaceuticals, Champions Oncology, and Aerovate Therapeutics. Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Opthea operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Foreign Associate
Australia
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
The reason investors look at the income statement is to determine what Opthea's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Opthea's current stock value. Our valuation model uses many indicators to compare Opthea value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Opthea competition to find correlations between indicators driving Opthea's intrinsic value. More Info.
Opthea is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Opthea's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Opthea by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Opthea Systematic Risk
Opthea's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Opthea volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Opthea correlated with the market. If Beta is less than 0 Opthea generally moves in the opposite direction as compared to the market. If Opthea Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Opthea is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Opthea is generally in the same direction as the market. If Beta > 1 Opthea moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Opthea Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Opthea's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Opthea growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Opthea help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Opthea. We use our internally-developed statistical techniques to arrive at the intrinsic value of Opthea based on widely used predictive technical indicators. In general, we focus on analyzing Opthea Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Opthea's daily price indicators and compare them against related drivers.
When running Opthea's price analysis, check to measure Opthea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opthea is operating at the current time. Most of Opthea's value examination focuses on studying past and present price action to predict the probability of Opthea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opthea's price. Additionally, you may evaluate how the addition of Opthea to your portfolios can decrease your overall portfolio volatility.